Trial intelligence / Profile preview

Carbidopa-Levodopa for Mobility Resilience in Older Adults

NCT06219915Phase 2Completed

Sponsor
University of Michigan
Start
Mar 2024
Primary completion
May 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of levodopa + carbidopa, sponsored by University of Michigan. Started Mar 2024; status: completed.

02

Drugs

levodopa + carbidopa

Beyond the preview

Go deeper on NCT06219915.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06219915.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call